Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5e7a9f9b6aa26ac3a15dfb7b4c82bc2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69b4de7d64ebafc368b849bca94eab18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-38 |
filingDate |
2007-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2843c584f76901f0f1e2310ac2db951 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52ccd216a9038eb7cca7ab31af6c4fcc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f04a404f9eb5ca03545a62e0ca5c2b4f |
publicationDate |
2009-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2009040692-A |
titleOfInvention |
Repair of muscle damage by transplanting human peripheral blood-derived CD133 / CD34 positive cells |
abstract |
An object of the present invention is to provide a method and a medicine for efficiently repairing muscle damage while suppressing scarring. The object is to find that when CD133-positive cells and / or CD34-positive cells are administered to a site of muscle damage, it is possible to efficiently repair the muscle damage while suppressing scarring. And / or by providing a pharmaceutical composition containing CD34 positive cells and providing a therapeutic method comprising administering CD133 positive cells and / or CD34 positive cells. [Selection figure] None |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9328085-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011158806-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9187728-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9212348-B2 |
priorityDate |
2007-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |